AAV-Follistatin gene therapy

AAV-delivered follistatin gene therapy · Unlimited Biotechnology LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV-Follistatin gene therapy, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy [Phase 1, Phase 2]

See pricing